Numerical, morphological and phenotypic changes in Langerhans cells in the course of murine graft-versus-host disease

British Journal of Dermatology

Volumn 145, Issue 6, 2001, Pages 918-927

  Asagoe, Kenji ^a   Takahashi, K ^a   Yoshino, T ^a   Kondo, E ^a   Tanaka, R ^a   Arata, J ^a   Akagi, T ^a  

^a OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Activation; Apoptosis; Graft versus host disease; Langerhans cells

Indexed keywords

B7 ANTIGEN; CD40 ANTIGEN; CD86 ANTIGEN; DEOXYURIDINE TRIPHOSPHATE DERIVATIVE; DNA NUCLEOTIDYLEXOTRANSFERASE; LIPOCORTIN 5; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL SUSPENSION; CONTROLLED STUDY; DENDRITE; EPIDERMIS CELL; FEMALE; FLOW CYTOMETRY; GRAFT VERSUS HOST REACTION; IMMUNOFLUORESCENCE; INOCULATION; LANGERHANS CELL; MORPHOLOGY; MOUSE; NICK END LABELING; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SKIN; SPLEEN CELL; T LYMPHOCYTE;

ANIMALS; ANTIGENS, CD; APOPTOSIS; CELL COUNT; EPIDERMIS; FEMALE; GRAFT VS HOST DISEASE; HISTOCOMPATIBILITY ANTIGENS CLASS II; IMMUNOPHENOTYPING; LANGERHANS CELLS; LYMPHOCYTE CULTURE TEST, MIXED; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, NUDE; MICROSCOPY, FLUORESCENCE; PHENOTYPE; UP-REGULATION;

EID: 0035724235     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.2001.04539.x     Document Type: Article

References (53)

1. Immunopathology of cutaneous graft-versus-host disease
2. Pathophysiology of graft-versus-host disease (GVHD) in animal models
3. Lymphocyte subsets and Langerhans' cells in toxic epidermal necrolysis. Report of a case
4. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors
5. Severe adverse cutaneous reactions to drugs
6. Graft-v-host disease
7. Toxic epidermal necrolysis (Lyell syndrome)
8. Apoptosis is the predominant form of epithelial target cell injury in acute experimental graft-versus-host disease
9. Apoptosis as a mechanism of keratinocyte death in toxic epidermal necrolysis
10. Epidermal apoptotic cell death in erythema multiforme and Stevens-Johnson syndrome. Contribution of perforin-positive cell infiltration
11. The loss of Ia+ Langerhans' cells during graft-versus-host disease in rats
12. Study of Langerhans cells after allogeneic bone marrow transplantation
13. Immunologic aspects of acute cutaneous graft-versus-host disease: Decreased density and antigen-presenting function of Ia+ Langerhans cells and absent antigen-presenting capacity of Ia+ keratinocytes
14. Depletion and repopulation of epidermal dendritic cells after allogeneic bone marrow transplantation in humans
15. Sequential immunohistologic analysis of the skin following allogeneic bone marrow transplantation
16. Lymphocyte subsets and Langerhans cells/indeterminate cells in erythema multiforme
17. Immunohistochemical study of graft-versus-host reaction (GVHR)-type drug eruptions
18. Effect of X-irradiation on epidermal immune function: Decreased density and alloantigen-presenting capacity of Ia+ Langerhans cells and impaired production of epidermal cell-derived thymocyte activating factor (ETAF)
19. Soft X-irradiation influences the integrity of Langerhans cells. A histochemical and immunohistological study
20. Epidermal Langerhans cells after allogeneic bone marrow transplantation: Depletion by chemotherapy conditioning regimen alone
21. Transfusion-associated graft-versus-host disease - Report of two further cases with an immunohistochemical analysis
22. Murine epidermal Langerhans cells mature into potent immunostimulatory dendritic cells in vitro
23. The dendritic cell system and its role in immunogenicity
24. Granulocyte/macrophage colony-stimulating factor is essential for the viability and function of cultured murine epidermal Langerhans cells
25. Granulocyte/macrophage colony-stimulating factor and interleukin 1 mediate the maturation of murine epidermal Langerhans cells into potent immunostimulatory dendritic cells
26. Interleukin 1 beta and the stimulation of Langerhans cell migration: Comparisons with tumour necrosis factor alpha
27. Langerhans cells require signals from both tumour necrosis factor-alpha and interleukin-1 beta for migration
28. Interleukin-1 beta and granulocyte-macrophage colony-stimulating factor mediate Langerhans cell maturation differently
29. Graft-versus-host disease
30. Graft-versus-host reactions in dermatology
31. Cutaneous graft-versus-host disease
32. Induction of cutaneous graft-versus-host disease by allo- or self-Ia-reactive helper T cells in mice
33. Studies on transient graft-versus-host disease in BALB/c nude mice injected with allogeneic C57BL/6 splenocytes
34. Langerhans' cells, veiled cells, and interdigitating cells in the mouse recognized by a monoclonal antibody
35. A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled annexin V
36. Experimental induction and ultrastructural characterization of apoptosis in murine acute cutaneous graft-versus-host disease
37. Migration and maturation of Langerhans cells in skin transplants and explants
38. Phenotypic and functional characteristics of in vivo-activated Langerhans cells
39. Induction of in vivo hyporesponsiveness to contact allergens by hapten-modified Ia+ keratinocytes
40. Localization of antigen on lymph node dendritic cells after exposure to the contact sensitizer fluorescein isothiocyanate. Functional and morphological studies
41. Evidence that cutaneous antigen-presenting cells migrate to regional lymph nodes during contact sensitization
42. Early molecular events in the induction phase of contact sensitivity
43. An essential role for Langerhans cell-derived IL-1 beta in the initiation of primary immune responses in skin
44. Bystander injury of host lymphoid tissue during murine graft-versus-host disease is mediated by nitric oxide
45. Cytokine storm of graft-versus-host disease: A critical effector role for interleukin-1
46. Interleukin-1 is a critical effector molecule during cytokine dysregulation in graft versus host disease to minor histocompatibility antigens
47. Increased serum levels of tumor necrosis factor alpha precede major complications of bone marrow transplantation
48. Cytokine gene expression in peripheral blood mononuclear cells during graft-versus-host disease after allogeneic bone marrow transplantation
49. Recent advances in graft-versus-host disease (GVHD) prevention
50. Prevention of graft versus host disease by inactivation of host antigen-presenting cells
51. Transplantation of anergic histoincompatible bone marrow allografts
52. Differential coupling of second signals for cytotoxicity and proliferation in CD8+ T cell effectors: Amplification of the lytic potential by B7
53. Distribution of the dendritic cell in human organs and the incidence of GVHD